Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

HIGHLIGHTS

• who: Henderikus E. Boersma from the Department of Endocrinology, University of Groningen, University Medical have published the research work: Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes, in the Journal: (JOURNAL)
• what: In Fig 1, the authors show the age-corrected SAF levels for participants with and without cardiovascular disease, in comparison with Lifelines participants without diabetes. The authors show that SAF is also significantly and independently associated with the combined outcome of new CVD events and mortality in people with type 2 diabetes.
• how: The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.